Olga Donica is a leading expert in translational longevity science and serves as Director of Innovation at Clinique La Prairie (CLP), where she bridges cutting-edge biomedical research with advanced clinical practice to shape the future of longevity medicine. She also serves on the Scientific Board of the Longevity Fund and chairs CLP’s Scientific Advisory Committee, driving innovation at the intersection of science, diagnostics, and therapeutics. In her R&D role, she oversees the scientific development of Holistic Health by Clinique La Prairie, a precision supplement line advancing health span. Currently pursuing a master’s in biology at Harvard University, specializing in biomedical sciences, she is a recognized thought leader featured in Financial Times, Vogue, and Monocle, and a frequent speaker at global longevity conferences such as FT Weekend, Longevity Med Summit, and Longevity Investor Conference. Her recent publications explore brain health, aging biomarkers, and nutrition-driven epigenetics

‍